TessArae Gets FDA Emergency Use Authorization for H1N1 Assay

The assay was developed through Affymetrix's MyGeneChip Custom Array Program. It is the latest in a series of molecular diagnostic products to get an FDA EUA.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.